-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

N/KRAS-Mutant Acute Myeloid Leukemia Stem Cells Originate from Committed Myelomonocytic Progenitors and Drive Clinical Resistance to Venetoclax

Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Post-Translational Underpinnings of Therapy Response and Resistance to Therapy
Hematology Disease Topics & Pathways:
Research, Fundamental Science
Friday, December 8, 2023, 3:29 PM-4:14 PM

Eirini Papapetrou, MD, Phd, MD, PhD

Icahn School of Medicine at Mount Sinai, New York, NY

Disclosures: No relevant conflicts of interest to declare.